# Major Recall Alert: APO-BRIMONIDINE-TIMOP Recalled Due to Weight Out of Specification in the Affected Lot
A recent product recall has been issued for **APO-BRIMONIDINE-TIMOP**, a medication used to treat certain eye conditions. The recall was announced because **the weight is out of specification in the affected lot**. It’s essential for consumers and healthcare providers to be aware of the potential issues this may pose to ensure continued safety and proper usage of medication. Here’s everything you need to know about this recall and what steps you should take if you are affected.
## Why This Recall is Important
When a medication's weight is out of specification, it can impact the **accuracy of dosing**, potentially reducing the intended effectiveness or causing unwanted side effects. Medications like APO-BRIMONIDINE-TIMOP are critical for managing specific medical conditions, and even minor inconsistencies can significantly impact a patient’s health and treatment outcome.
Product recalls are conducted to ensure the **safety and well-being of consumers**, and it is important for anyone using the affected lot of this product to address the issue promptly.
### Key Concerns Surrounding the Recall:
- **Affected Category**: Health products (Canada).
- **Reason for Recall**: Weight not meeting required standards in the affected lot.
- **Health Impact**: Inconsistent medication weight can affect proper dosing and desired treatment results.
## Details of the Recall
The recall pertains to **APO-BRIMONIDINE-TIMOP**, specifically related to a batch identified with weight discrepancies. If you use this medication or are a healthcare provider prescribing it, it is important to verify if your product is from the affected lot. Below are the essential details:
- **Product Name**: APO-BRIMONIDINE-TIMOP
- **Brand**: APO-BRIMONIDINE-TIMOP
- **Recall Reason**: The weight is out of specification in the identified lot.
- **Announcement Date**: October 2023
- **Health Canada Recall Official Source**: [Click here for more information](https://recalls-rappels.canada.ca/en/alert-recall/apo-brimonidine-timop-weight-out-specification-affected-lot).
This type of recall is aimed at preventing complications associated with inaccurate dosing. If there are further updates from Health Canada, they will likely be communicated via their official channels.
## What You Should Do
If you currently have APO-BRIMONIDINE-TIMOP in your possession or if you’re a healthcare professional prescribing this product, follow these steps to ensure safety:
- **Check the Lot Number**: Confirm whether your medication belongs to the affected lot. Contact the pharmacy or healthcare provider where you obtained the product for more details.
- **Stop Use Immediately**: If your product is from the impacted lot, halt use and consult your healthcare provider to discuss alternative treatments or solutions.
- **Follow Disposal Instructions**: The pharmacy may also provide guidance on proper medication disposal to ensure it is handled safely.
- **Report Adverse Reactions**: If you or someone you know experiences any side effects or issues with the medication, report it to Health Canada immediately.
Don’t wait—take action now to protect your health and avoid potential risks.
## Stay Safe – Get Instant Recall Alerts
The best way to safeguard against product recalls is to stay informed. By signing up for instant recall alerts, you’ll never miss critical updates that could impact your health or safety.
**Take control of your safety today—download the official Recall App now to stay ahead of all product recalls and health alerts!**
Stay informed, stay safe, and always prioritize your health. For full details on this recall, visit the **[official Health Canada recall page](https://recalls-rappels.canada.ca/en/alert-recall/apo-brimonidine-timop-weight-out-specification-affected-lot)**.